Clinical characteristics of liver failure from a systemic cause: A report from an advanced critical care center
Journal Title: Annals of Hepatology - Year 2016, Vol 15, Issue 2
Abstract
Background/Purpose. In Japan, acute liver failure (ALF) has generally been described using the diagnostic term, “fulminant hepatitis”, because of the fact that most cases of ALF has been thought to occur in association with hepatitis mainly due to a hepatitis virus infection. New diagnostic criteria for ALF, including ALF other than fulminant hepatitis, were established in 2011. Wetherefore examined the prognostic factors of patients with liver failure from a systemic cause, including warfarin users. Materialand methods. Sixty-six patients with ALF that were diagnosed according to the Japanese diagnostic criteria for ALF between2009 and 2013 were divided into a survivor group and a non-survivor group. The data regarding demography, liver tests, coagulation tests, Sequential Organ Failure Assessment (SOFA) scores, and the use of oral warfarin or aspirin were compared between the two groups. Results. The SOFA score was significantly higher in the non-survivor group (p = 0.025). The proportion of oral warfarin users was significantly higher in the survivor group (p = 0.013) (58.1% vs. 26.1%). A multivariate logistic regression analysis showed the SOFA score (odds ratio: 0.851, 95% confidence interval (CI): 0.728-0.995, p = 0.043) and warfarin use (odds ratio: 3.261, 95% CI: 1.028-10.347, p = 0.045) to be significant factors that were negatively and positively associated with the prognosis, respectively. Conclusion. In this study, among the patients with ALF other than fulminant hepatitis, those with a high SOFA score on admission exhibited a poor prognosis. In addition, oral warfarin use prior to disease onset was found to be a factor which indicated a good prognosis.
Authors and Affiliations
Makoto Onodera, Yoshihiro Inoue, Yasuhiro Takikawa, Shigeatsu Endo
Keywords
Related Articles
- EP ID EP78563
- DOI -
- Views 165
- Downloads 0
Prevalence of minimal hepatic encephalopathy in cirrhotic patients
Background. Minimal hepatic encephalopathy (MHE) has implications for health-related quality of life as well as for survival of cirrhotic patients, but a standardized diagnostic test is not available. Objective. To deter...
Acute and fulminant hepatitis induced by flutamide: Case series report and review of the literature
Flutamide is a non-steroidal anti-androgenic drug, commonly used in the treatment of advanced prostate cancer, acne and hirsutism. This drug may induce various degrees of liver injury, including acute liver failure (ALF)...
Portal hypertension and acute liver failure as uncommon manifestations of primary amyloidosis
Hepatic involvement in primary amyloidosis is an infrequent challenge to the hepatologist. Although usually asymptomatic, amyloidosis may have unusual manifestations. Liver biopsy is an important diagnostic tool for this...
Albumin dialysis with molecular adsorbent recirculating system (MARS) for the treatment of hepatic encephalopathy in liver failure
Acute, acute-on-chronic and chronic liver diseases are major health issues worldwide, and most cases end with the need for liver transplantation. Up to 90% of the patients die waiting for an organ to be transplanted. Hep...
Citrus auraptene: A potential multifunctional therapeutic agent for nonalcoholic fatty liver disease